SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-01 18:43
Tx date 2023-05-12 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
55 - Expiration of warrants 		$-16,537.50
-7,875 vol
$2.10 each 		0
Filed 2024-03-28 21:13
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus 		$66,105
+22,035 vol
$3.00 each 		22,035
Filed 2024-03-28 21:12
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-28 21:10
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus 		$103,564
+44,070 vol
$2.35 each 		155,820
Filed 2024-02-21 00:12
Tx date 2024-02-19 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$278,400
+80,000 vol
$3.48 each 		1,180,000
Filed 2023-02-24 16:19
Tx date 2023-02-22 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$155,200
+80,000 vol
$1.94 each 		1,100,000
Filed 2022-04-27 20:31
Tx date 2022-04-27 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
54 - Exercise of warrants 		$76,800
+48,000 vol
$1.60 each 		111,750
Filed 2022-04-27 20:24
Tx date 2022-04-27 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
54 - Exercise of warrants
-48,000 vol 		7,875
Filed 2022-03-07 16:44
Tx date 2022-03-01 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$164,800
+80,000 vol
$2.06 each 		1,020,000
Filed 2021-05-14 13:55
Tx date 2021-05-12 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus 		$16,537
+7,875 vol
$2.10 each 		55,875
Filed 2021-05-14 13:52
Tx date 2021-05-12 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus 		$24,412
+15,750 vol
$1.55 each 		63,750
Filed 2021-05-14 13:39
Tx date 2021-05-12 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$16,537
+7,875 vol
$2.10 each
Filed 2021-05-14 13:37
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-14 13:37
Tx date 2021-05-12 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$24,412
+15,750 vol
$1.55 each
Filed 2021-05-14 13:35
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-06 19:34
Tx date 2021-04-23 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$132,000
+80,000 vol
$1.65 each 		940,000
Filed 2020-05-21 14:51
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:50
Tx date 2020-05-20 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
16 - Acquisition or disposition under a prospectus exemption 		$60,000
+48,000 vol
$1.25 each
Filed 2020-05-21 14:49
Tx date 2020-05-20 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$60,000
+48,000 vol
$1.25 each 		48,000
Filed 2020-05-21 14:48
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:46
Tx date 2020-05-20 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$60,000
+48,000 vol
$1.25 each 		48,000
Filed 2020-05-21 14:45
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:31
Tx date 2020-05-20 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
16 - Acquisition or disposition under a prospectus exemption 		$60,000
+48,000 vol
$1.25 each
Filed 2020-05-21 14:29
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:28
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-14 19:57
Tx date 2020-04-06 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$67,800
+60,000 vol
$1.13 each 		860,000
Filed 2020-02-26 09:34
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+800,000 vol 		800,000
Filed 2020-02-26 09:32
Tx date 2020-02-21 		$NGEN
NervGen Pharma Corp. 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-24
Tx date 2015-12-22 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$15,000
+25,000 vol
$0.60 each 		308,500
Filed 2015-11-30
Tx date 2015-11-25 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$3,500
+5,000 vol
$0.70 each 		36,100
Filed 2015-11-30
Tx date 2015-11-25 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$201.00
+300 vol
$0.67 each 		36,400
Filed 2015-11-30
Tx date 2015-11-25 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$6,300
+10,500 vol
$0.60 each 		31,100
Filed 2015-11-20
Tx date 2015-11-17 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$500.00
+1,000 vol
$0.50 each 		6,000
Filed 2015-11-20
Tx date 2015-11-17 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$726.00
+1,100 vol
$0.66 each 		20,600
Filed 2015-11-20
Tx date 2015-11-17 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$7,150
+11,000 vol
$0.65 each 		19,500
Filed 2015-11-20
Tx date 2015-11-17 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$320.00
+500 vol
$0.64 each 		8,500
Filed 2015-11-20
Tx date 2015-11-17 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Holder: RBC Dominion Securities Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,280
+2,000 vol
$0.64 each 		8,000
Filed 2015-05-22
Tx date 2015-05-19 		$RBM
Response Biomedical Corp 		Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$108,000
+150,000 vol
$0.72 each 		283,500